Apyx Medical Corporation (APYX)
USD 1.0
(-13.79%)
USD 1.0
(-13.79%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 9.92 Million USD | -15.89% |
| 2022 | 11.79 Million USD | 74.05% |
| 2021 | 6.77 Million USD | 67.32% |
| 2020 | 4.05 Million USD | -19.78% |
| 2019 | 5.05 Million USD | -3.11% |
| 2018 | 5.21 Million USD | -20.13% |
| 2017 | 6.52 Million USD | 5.98% |
| 2016 | 6.15 Million USD | 3.37% |
| 2015 | 5.95 Million USD | 4.02% |
| 2014 | 5.72 Million USD | -31.94% |
| 2013 | 8.41 Million USD | 5.4% |
| 2012 | 7.98 Million USD | -2.37% |
| 2011 | 8.17 Million USD | 7.53% |
| 2010 | 7.6 Million USD | 12.26% |
| 2009 | 6.77 Million USD | 16.03% |
| 2008 | 5.83 Million USD | 29.11% |
| 2007 | 4.52 Million USD | 25.29% |
| 2006 | 3.6 Million USD | 20.44% |
| 2005 | 2.99 Million USD | 49.72% |
| 2004 | 2 Million USD | -18.34% |
| 2003 | 2.45 Million USD | 3.97% |
| 2002 | 2.35 Million USD | -2.58% |
| 2001 | 2.41 Million USD | 21.32% |
| 2000 | 1.99 Million USD | 18.88% |
| 1999 | 1.67 Million USD | 13.63% |
| 1998 | 1.47 Million USD | 54.92% |
| 1997 | 953.12 Thousand USD | 11.61% |
| 1996 | 854 Thousand USD | 40.88% |
| 1995 | 606.2 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 9.32 Million USD | -4.81% |
| 2024 Q1 | 9.79 Million USD | -1.29% |
| 2023 Q2 | 11.16 Million USD | 2.02% |
| 2023 Q4 | 9.92 Million USD | -12.07% |
| 2023 Q1 | 10.94 Million USD | -7.21% |
| 2023 FY | 9.92 Million USD | -15.89% |
| 2023 Q3 | 11.28 Million USD | 1.06% |
| 2022 Q1 | 7.01 Million USD | 3.56% |
| 2022 Q2 | 9.67 Million USD | 37.87% |
| 2022 Q3 | 12.04 Million USD | 24.44% |
| 2022 Q4 | 11.79 Million USD | -2.03% |
| 2022 FY | 11.79 Million USD | 74.05% |
| 2021 Q4 | 6.77 Million USD | 12.22% |
| 2021 FY | 6.77 Million USD | 67.32% |
| 2021 Q1 | 4.46 Million USD | 10.17% |
| 2021 Q2 | 5.27 Million USD | 18.13% |
| 2021 Q3 | 6.04 Million USD | 14.57% |
| 2020 Q1 | 5.87 Million USD | 16.28% |
| 2020 Q2 | 5.25 Million USD | -10.47% |
| 2020 Q3 | 5.41 Million USD | 3.02% |
| 2020 Q4 | 4.05 Million USD | -25.2% |
| 2020 FY | 4.05 Million USD | -19.78% |
| 2019 FY | 5.05 Million USD | -3.11% |
| 2019 Q4 | 5.05 Million USD | -30.22% |
| 2019 Q3 | 7.23 Million USD | 13.22% |
| 2019 Q2 | 6.39 Million USD | 14.18% |
| 2019 Q1 | 5.59 Million USD | 7.41% |
| 2018 Q1 | 6.7 Million USD | 2.8% |
| 2018 FY | 5.21 Million USD | -20.13% |
| 2018 Q4 | 5.21 Million USD | -13.67% |
| 2018 Q3 | 6.03 Million USD | -19.86% |
| 2018 Q2 | 7.53 Million USD | 12.28% |
| 2017 Q2 | 7.58 Million USD | 2.16% |
| 2017 Q3 | 7.33 Million USD | -3.26% |
| 2017 Q4 | 6.52 Million USD | -11.03% |
| 2017 FY | 6.52 Million USD | 5.98% |
| 2017 Q1 | 7.42 Million USD | 20.53% |
| 2016 FY | 6.15 Million USD | 3.37% |
| 2016 Q1 | 6.56 Million USD | 10.14% |
| 2016 Q2 | 6.41 Million USD | -2.23% |
| 2016 Q3 | 5.93 Million USD | -7.56% |
| 2016 Q4 | 6.15 Million USD | 3.84% |
| 2015 FY | 5.95 Million USD | 4.02% |
| 2015 Q3 | 6.13 Million USD | -3.46% |
| 2015 Q2 | 6.35 Million USD | 3.59% |
| 2015 Q1 | 6.13 Million USD | 7.04% |
| 2015 Q4 | 5.95 Million USD | -2.82% |
| 2014 Q4 | 5.72 Million USD | -11.66% |
| 2014 Q3 | 6.48 Million USD | -6.34% |
| 2014 Q2 | 6.92 Million USD | -16.27% |
| 2014 FY | 5.72 Million USD | -31.94% |
| 2014 Q1 | 8.26 Million USD | -1.76% |
| 2013 Q1 | 8.53 Million USD | 6.93% |
| 2013 Q3 | 8.52 Million USD | 3.45% |
| 2013 Q4 | 8.41 Million USD | -1.3% |
| 2013 FY | 8.41 Million USD | 5.4% |
| 2013 Q2 | 8.24 Million USD | -3.46% |
| 2012 Q4 | 7.98 Million USD | 2.58% |
| 2012 FY | 7.98 Million USD | -2.37% |
| 2012 Q1 | 8.04 Million USD | -1.68% |
| 2012 Q2 | 7.35 Million USD | -8.53% |
| 2012 Q3 | 7.78 Million USD | 5.82% |
| 2011 Q2 | 7.21 Million USD | -2.54% |
| 2011 FY | 8.17 Million USD | 7.53% |
| 2011 Q4 | 8.17 Million USD | 6.79% |
| 2011 Q3 | 7.65 Million USD | 6.14% |
| 2011 Q1 | 7.4 Million USD | -2.66% |
| 2010 Q1 | 6.98 Million USD | 3.18% |
| 2010 FY | 7.6 Million USD | 12.26% |
| 2010 Q3 | 7.72 Million USD | 7.62% |
| 2010 Q4 | 7.6 Million USD | -1.59% |
| 2010 Q2 | 7.18 Million USD | 2.74% |
| 2009 Q2 | 7.09 Million USD | 8.72% |
| 2009 FY | 6.77 Million USD | 16.03% |
| 2009 Q3 | 7.07 Million USD | -0.26% |
| 2009 Q4 | 6.77 Million USD | -4.23% |
| 2009 Q1 | 6.52 Million USD | 11.73% |
| 2008 Q2 | 4.93 Million USD | 0.25% |
| 2008 Q4 | 5.83 Million USD | 7.26% |
| 2008 FY | 5.83 Million USD | 29.11% |
| 2008 Q1 | 4.92 Million USD | 8.95% |
| 2008 Q3 | 5.44 Million USD | 10.21% |
| 2007 Q1 | 4.18 Million USD | 15.86% |
| 2007 FY | 4.52 Million USD | 25.29% |
| 2007 Q2 | 4.47 Million USD | 6.92% |
| 2007 Q3 | 4.68 Million USD | 4.69% |
| 2007 Q4 | 4.52 Million USD | -3.39% |
| 2006 Q1 | 3.27 Million USD | 9.4% |
| 2006 Q2 | 3.26 Million USD | -0.54% |
| 2006 Q3 | 3.37 Million USD | 3.59% |
| 2006 FY | 3.6 Million USD | 20.44% |
| 2006 Q4 | 3.6 Million USD | 6.85% |
| 2005 Q3 | 2.85 Million USD | 13.38% |
| 2005 Q4 | 2.99 Million USD | 4.98% |
| 2005 Q2 | 2.51 Million USD | 10.8% |
| 2005 Q1 | 2.27 Million USD | 13.53% |
| 2005 FY | 2.99 Million USD | 49.72% |
| 2004 Q2 | 2.42 Million USD | -5.09% |
| 2004 Q1 | 2.55 Million USD | 4.39% |
| 2004 Q4 | 2 Million USD | -0.17% |
| 2004 Q3 | 2 Million USD | -17.44% |
| 2004 FY | 2 Million USD | -18.34% |
| 2003 FY | 2.45 Million USD | 3.97% |
| 2003 Q1 | 2.58 Million USD | 9.64% |
| 2003 Q4 | 2.45 Million USD | -4.22% |
| 2003 Q3 | 2.55 Million USD | -0.17% |
| 2003 Q2 | 2.56 Million USD | -0.83% |
| 2002 Q2 | 2.49 Million USD | -0.09% |
| 2002 Q4 | 2.35 Million USD | -9.27% |
| 2002 FY | 2.35 Million USD | -2.58% |
| 2002 Q3 | 2.59 Million USD | 4.16% |
| 2002 Q1 | 2.49 Million USD | 3.19% |
| 2001 FY | 2.41 Million USD | 21.32% |
| 2001 Q1 | 2.11 Million USD | 6.13% |
| 2001 Q2 | 2.12 Million USD | 0.2% |
| 2001 Q3 | 2.42 Million USD | 14.23% |
| 2001 Q4 | 2.41 Million USD | -0.13% |
| 2000 Q4 | 1.99 Million USD | 6.51% |
| 2000 Q1 | 1.8 Million USD | 6.46% |
| 2000 FY | 1.99 Million USD | 18.88% |
| 2000 Q3 | 1.87 Million USD | -0.23% |
| 2000 Q2 | 1.87 Million USD | 3.71% |
| 1999 FY | 1.67 Million USD | 13.63% |
| 1999 Q1 | 1.5 Million USD | 0.0% |
| 1999 Q2 | 1.5 Million USD | 0.0% |
| 1999 Q3 | 1.5 Million USD | 0.0% |
| 1999 Q4 | 1.7 Million USD | 13.33% |
| 1998 Q1 | 1.1 Million USD | 10.0% |
| 1998 Q2 | 2.1 Million USD | 90.91% |
| 1998 Q3 | 2 Million USD | -4.76% |
| 1998 Q4 | 1.5 Million USD | -25.0% |
| 1998 FY | 1.47 Million USD | 54.92% |
| 1997 Q2 | 1 Million USD | -9.09% |
| 1997 Q1 | 1.1 Million USD | 22.22% |
| 1997 Q4 | 1 Million USD | 0.0% |
| 1997 FY | 953.12 Thousand USD | 11.61% |
| 1997 Q3 | 1 Million USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | 16.67% |
| 1996 FY | 854 Thousand USD | 40.88% |
| 1996 Q3 | 800 Thousand USD | 14.29% |
| 1996 Q1 | 600 Thousand USD | 0.0% |
| 1996 Q4 | 900 Thousand USD | 12.5% |
| 1995 Q4 | 600 Thousand USD | 0.0% |
| 1995 FY | 606.2 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -199.789% |
| BrainsWay Ltd. | 3.71 Million USD | -166.963% |
| Cerus Corporation | 39.86 Million USD | 75.11% |
| Envoy Medical, Inc. | 1.4 Million USD | -606.766% |
| electroCore, Inc. | 2.16 Million USD | -359.398% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -2071.335% |
| IceCure Medical Ltd | 2.27 Million USD | -336.176% |
| Inogen, Inc. | 21.84 Million USD | 54.565% |
| OrthoPediatrics Corp. | 105.85 Million USD | 90.626% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -3469.424% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -992299900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 18.857% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -474.685% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -6243.818% |
| Orthofix Medical Inc. | 222.16 Million USD | 95.534% |
| PAVmed Inc | 1.01 Million USD | -875.714% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 50.288% |
| RxSight, Inc. | 17.42 Million USD | 43.04% |
| Sight Sciences, Inc. | 7.84 Million USD | -26.424% |
| SI-BONE, Inc. | 20.24 Million USD | 50.995% |
| TELA Bio, Inc. | 13.16 Million USD | 24.609% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 66.069% |
| Vivos Therapeutics, Inc. | 1.00 USD | -992299900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -131.954% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -4214.348% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -321.18% |
| CVRx, Inc. | 10.98 Million USD | 9.651% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -2443.863% |
| Bioventus Inc. | 91.33 Million USD | 89.135% |
| Venus Concept Inc. | 28.67 Million USD | 65.396% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -289.902% |
| LivaNova PLC | 147.88 Million USD | 93.29% |
| 908 Devices Inc. | 14.93 Million USD | 33.572% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 92.749% |
| Nemaura Medical Inc. | 1.75 Million USD | -465.461% |
| NeuroPace, Inc. | 11.21 Million USD | 11.512% |
| LENSAR, Inc. | 15.68 Million USD | 36.752% |
| Cutera, Inc. | 72.1 Million USD | 86.237% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -271.231% |
| BioSig Technologies, Inc. | -103 Thousand USD | 9733.981% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 78.608% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -25.433% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 97.453% |
| Axonics, Inc. | 79.94 Million USD | 87.587% |
| Outset Medical, Inc. | 49.21 Million USD | 79.837% |
| IRIDEX Corporation | 9.9 Million USD | -0.172% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 75.04% |
| IRadimed Corporation | 12.82 Million USD | 22.605% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -1212.566% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -3651.508% |
| Telesis Bio, Inc. | 4.02 Million USD | -146.534% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -115.515% |
| Varex Imaging Corporation | 277.5 Million USD | 96.424% |
| Quipt Home Medical Corp. | 18.32 Million USD | 45.852% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 40.733% |
| Dynatronics Corporation | 5.59 Million USD | -77.387% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -165.25% |
| Semler Scientific, Inc. | 445 Thousand USD | -2129.888% |
| InMode Ltd. | 45.09 Million USD | 77.995% |
| Bruker Corporation | 968.3 Million USD | 98.975% |
| Cytosorbents Corporation | 3.68 Million USD | -169.637% |
| DexCom, Inc. | 559.6 Million USD | 98.227% |
| Align Technology, Inc. | 296.9 Million USD | 96.658% |
| Viveve Medical, Inc. | 1.47 Million USD | -574.117% |
| ZimVie Inc. | 79.6 Million USD | 87.534% |
| Movano Inc. | 1.51 Million USD | -555.849% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 83.7% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -6243.818% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 93.717% |
| Profound Medical Corp. | 6.95 Million USD | -42.71% |
| Insulet Corporation | 402.6 Million USD | 97.535% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 33.129% |
| iCAD, Inc. | 917 Thousand USD | -982.116% |
| Nuwellis, Inc. | 1.99 Million USD | -396.895% |
| Biotricity, Inc. | 1.87 Million USD | -427.987% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 28.984% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -371.178% |
| PAVmed Inc. | 1.01 Million USD | -875.714% |
| BIOLASE, Inc. | 11.43 Million USD | 13.207% |
| Beyond Air, Inc. | 2.12 Million USD | -366.526% |
| FONAR Corporation | 2.71 Million USD | -265.429% |
| AxoGen, Inc. | 23.02 Million USD | 56.894% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 55.951% |
| Inari Medical, Inc. | 42.9 Million USD | 76.869% |
| UFP Technologies, Inc. | 70.19 Million USD | 85.863% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -1477.135% |
| Tenon Medical, Inc. | 554 Thousand USD | -1691.155% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -496.074% |
| AdaptHealth Corp. | 113.64 Million USD | 91.268% |
| Sintx Technologies, Inc. | 888 Thousand USD | -1017.455% |
| NanoVibronix, Inc. | 2.73 Million USD | -263.214% |
| Quanterix Corporation | 22.36 Million USD | 55.632% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 33.165% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 82.492% |
| TransMedics Group, Inc. | 44.23 Million USD | 77.568% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -75.535% |
| NeuroMetrix, Inc. | 1.55 Million USD | -536.323% |
| Hyperfine, Inc. | 6.58 Million USD | -50.76% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 87.587% |
| Biomerica, Inc. | 2.37 Million USD | -317.635% |
| Bone Biologics Corporation | -328.84 Thousand USD | 3117.54% |
| AVITA Medical, Inc. | 3.12 Million USD | -217.901% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 66.786% |